Indies Pharma Jamaica Company Description
Indies Pharma Jamaica Limited engages in the distribution and retail of pharmaceutical and auxiliary products in Jamaica.
It offers prescription and over the counter drugs in tablet, topical creams, ointment, suspension, injection, capsule, sachet and dispersible tablet, oral mixture, cream, solution, gel, shampoo, drop, chewable tablet, syrup, nasal spray, vaginal cream and pessary, tonic, and oral powder and solution dosage forms.
The company provides its products for use as cardiovascular agents, including anti-hypertensive, circulation and anti-thrombotic, anti-cholesterol, venous circulation and hemorrhoids, gastro-intestinal, antibiotic, anti-diabetes, and antiviral agents.
In addition, it provides dermatology agents, such as antibiotics topical, antifungal, dermatology and anti-acne, NSAIDS and antipyretic, respiratory/ENT and allergy, cough and cold, ophthalmology, vaginal preparation, appetite stimulant, hematinics and vitamins, neurological, anti-psychiatry, steroids, hormones and contraceptives, oncological, anesthesiology, biotechnology/biosimilars, and nephrology agents, as well as contrast media for radiology.
The company was incorporated in 2003 and is headquartered in Montego Bay, Jamaica. Indies Pharma Jamaica Limited is a subsidiary of Bioprist Holdings Inc.
Country | Jamaica |
Founded | 2003 |
Industry | Drugs, Drug Proprietaries, and Druggists' Sundries |
Employees | 71 |
CEO | Guna Muppuri |
Contact Details
Address: 1A Pimento Way Montego Bay Jamaica | |
Phone | 876 940 7984 |
Website | indiespharma.com |
Stock Details
Ticker Symbol | INDIES |
Exchange | Jamaica Stock Exchange |
Fiscal Year | November - October |
Reporting Currency | JMD |
SIC Code | 5122 |
Key Executives
Name | Position |
---|---|
Guna Muppuri | Chief Executive Officer |
Vishnu Muppuri | Chief Operating Officer |